Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
46
DHC Quote, Financials, Valuation and Earnings
Last price:
$4.90
Seasonality move
:
5.09%
Day range:
$4.85 - $5.02
52-week range:
$2.00 - $5.16
Dividend yield:
0.82%
P/E ratio:
--
P/S ratio:
0.76x
P/B ratio:
0.70x
Volume:
342.3K
Avg. volume:
980.4K
1-year change:
121.27%
Market cap:
$1.2B
Revenue:
$1.5B
EPS (TTM):
-$1.47
Analysts' Opinion
-
Consensus RatingDiversified Healthcare Trust has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $5.75, Diversified Healthcare Trust has an estimated upside of 17.59% from its current price of $4.89.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.00 representing 100% downside risk from its current price of $4.89.
Fair Value
-
According to the consensus of 3 analysts, Diversified Healthcare Trust has 17.59% upside to fair value with a price target of $5.75 per share.
DHC vs. S&P 500
-
Over the past 5 trading days, Diversified Healthcare Trust has underperformed the S&P 500 by -2.99% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Diversified Healthcare Trust does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Diversified Healthcare Trust has grown year-over-year revenues for 12 quarters straight. In the most recent quarter Diversified Healthcare Trust reported revenues of $388.7M.
Earnings Growth
-
Diversified Healthcare Trust earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Diversified Healthcare Trust reported earnings per share of -$0.68.
Enterprise value:
3.7B
EV / Invested capital:
0.84x
Price / LTM sales:
0.76x
EV / EBIT:
--
EV / Revenue:
2.42x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
-22.87x
Price / Operating cash flow:
9.80x
Enterprise value / EBITDA:
15.67x
Gross Profit (TTM):
-$7M
Return On Assets:
-7.08%
Net Income Margin (TTM):
-22.9%
Return On Equity:
-18.53%
Return On Invested Capital:
-7.46%
Operating Margin:
-4.1%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.4B | $1.5B | $1.5B | $373.6M | $388.7M | |
| Gross Profit | -$34M | -$38.5M | -$7M | -$5M | -$2M | |
| Operating Income | -$66.6M | -$75.6M | -$40.2M | -$19.3M | -$16M | |
| EBITDA | $197.1M | $215.5M | $237.2M | $49.7M | $49.4M | |
| Diluted EPS | -$1.07 | -$1.61 | -$1.47 | -$0.41 | -$0.68 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $919.6M | $875.4M | $378.6M | $416.7M | $530.1M | |
| Total Assets | $7.1B | $6.1B | $5.5B | $5.3B | $4.7B | |
| Current Liabilities | $47.2M | $32.2M | $32.5M | $25.2M | $365.4M | |
| Total Liabilities | $4.7B | $3.4B | $3.1B | $3.2B | $3B | |
| Total Equity | $2.4B | $2.7B | $2.4B | $2B | $1.7B | |
| Total Debt | $4.4B | $3.1B | $2.8B | $3B | $2.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $14.3M | $86.8M | $18.7M | $21.1M | -$49.3M | |
| Cash From Investing | -$246.9M | -$172.1M | $210M | -$25.2M | $6.1M | |
| Cash From Financing | -$289.1M | $67.6M | -$280.5M | -$4.6M | $104.2M | |
| Free Cash Flow | -$264.4M | -$114.8M | -$162.4M | -$26.1M | -$89.8M | |
DHC
Sector
Market Cap
$1.2B
$967.4M
Price % of 52-Week High
94.86%
86%
Dividend Yield
0.82%
2.41%
Shareholder Yield
4.77%
3.09%
1-Year Price Total Return
121.27%
--
Beta (5-Year)
2.391
0.644
Dividend yield:
0.82%
Annualized payout:
$0.04
Payout ratio:
3.36%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$4.97
200-day SMA
Buy
Level
$3.65
Bollinger Bands (100)
Buy
Level
3.85 - 4.75
Chaikin Money Flow
Buy
Level
19M
20-day SMA
Buy
Level
$4.87
Relative Strength Index (RSI14)
Buy
Level
53.73
ADX Line
Buy
Level
23.22
Williams %R
Neutral
Level
-52.4752
50-day SMA
Buy
Level
$4.57
MACD (12, 26)
Buy
Level
0.11
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
21.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.3468)
Sell
CA Score
(Annual)
Level (-0.8337)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (0.8613)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. It operates through the Medical Office and Life Science Portfolio and SHOP segments. The Medical Office and Life Science Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. The SHOP segment manages senior living communities that provide short term and long-term residential living and, in some instances, care and other services for residents where pay fees to managers to operate the communities. The company was founded on December 16, 1998 and is headquartered in Newton, MA.
Stock Forecast FAQ
In the current month, DHC has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The DHC average analyst price target in the past 3 months is $5.75.
-
Where Will Diversified Healthcare Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Diversified Healthcare Trust share price will rise to $5.75 per share over the next 12 months.
-
What Do Analysts Say About Diversified Healthcare Trust?
Analysts are divided on their view about Diversified Healthcare Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Diversified Healthcare Trust is a Sell and believe this share price will drop from its current level to $5.00.
-
What Is Diversified Healthcare Trust's Price Target?
The price target for Diversified Healthcare Trust over the next 1-year time period is forecast to be $5.75 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is DHC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Diversified Healthcare Trust is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of DHC?
You can purchase shares of Diversified Healthcare Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Diversified Healthcare Trust shares.
-
What Is The Diversified Healthcare Trust Share Price Today?
Diversified Healthcare Trust was last trading at $4.90 per share. This represents the most recent stock quote for Diversified Healthcare Trust. Yesterday, Diversified Healthcare Trust closed at $4.89 per share.
-
How To Buy Diversified Healthcare Trust Stock Online?
In order to purchase Diversified Healthcare Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get DHC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DHC
Sector
P/E ratio
--
17.40x
PEG ratio
-0.07x
0.05x
P/B ratio
0.70x
0.80x
Price / LTM sales
0.76x
3.15x
Growth Metrics
DHC
Sector
Revenue growth
4.03%
3.18%
Earnings growth
-65.71%
6.29%
Revenue (5-year growth)
7.53%
2.86%
Earnings forecast
-$0.23
$0.15
Profitability
DHC
Sector
Profitability FY 2024
-$26.1M
$154.7M
Return on invested capital
-7.46%
2.03%
Return on assets
-7.08%
1.81%
Return on equity
-18.53%
3.5%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Feb
24
Estimated Next Earnings Date
Feb
2
Balance Sheet
DHC
Sector
Total cash
$209.6M
$73.8M
Short term investments
--
$11.9M
Total assets
$5.1B
$3.2B
Long term debt
$2.7B
$349.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
87
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
60
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
